Interestingly, there was very little overlap between the proteomic profiles of the different SMA types, with not one single protein being significantly altered across all types, resulting in a lack of conserved molecular responses to reduced SMN levels with SMA severity. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.